◀ Back to ANXA6
ANXA6 — HGF
Text-mined interactions from Literome
Skrtic et al., Endocrinology 1999
:
Inhibition of
p70S6K activation by rapamycin
blocked IGF-1 induced DNA synthesis but not the increase in
HGF
Chandrasekher et al., Exp Eye Res 2001
(MAP Kinase Signaling System) :
HGF increased
p70 S6K activity by 300 % and KGF by about 200 %
Okano et al., Biochem Biophys Res Commun 2003
:
The activation of AKT,
p70 ( s6k ), and ERK1/2
induced by
HGF was abolished by pre-treatment with LY294002, a phosphoinositide 3-OH kinase (PI3K) inhibitor, and U0126, a mitogen activated protein kinase/ERK kinase ( MEK ) inhibitor, respectively
Ishikawa et al., PloS one 2013
:
Both temsirolimus and everolimus inhibited the phosphorylation of
p70S6K and 4E-BP1, which are downstream targets of the mTOR pathway, and
reduced the viability of EGFR mutant lung cancer cells, PC-9, and HCC827, even in the presence of
HGF in vitro